HC Wainwright & Co. Reinstates Neutral on First Wave BioPharma

Benzinga · 03/25 10:44
HC Wainwright & Co. analyst Yi Chen reinstates First Wave BioPharma (NASDAQ:FWBI) with a Neutral.